Facial Scars
Conditions
Brief summary
Most of the body's tissues can undergo wound repair following a disruption of tissue integrity. Upon healing, these wounds result in scar formation. The scars widen when the overlying musculature pulls apart suture lines. Botulinum Toxin A (BTA) is known to prevent fibroblast proliferation and it also induces temporary muscle paralysis. Also, mesotherapy is the non-invasive transdermal injection which can aid the skin to increase collagen and elastin production. Thus, both techniques are eligible for enhancement of facial scars.
Interventions
Patients will receive BTA injection within a period of 5 days after primary closure.
Patients will receive mesotherapy growth factor serum with a derma pen within a period of 5 days after primary closure.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient suffering from vertical or oblique forehead lacerations caused by trauma. * Recent and fresh wounds. * Atrophic scar (linear scar).
Exclusion criteria
* Infected wound. * Patient on chemotherapy treatment and history of malignancy. * Patients suffering from burns on the forehead or complicated lacerations. * Allergy to drugs used in this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in scar appearance | Baseline, 1 month, 3 months, 6 months | The Vancouver Scar Scale (VSS) will be measured to calculate scar appearance. The VSS evaluates four indicators: vascularity, pigmentation, pliability, and height. It has a score ranging from 0-13. * Vascularity: Normal 0, Pink 1, Red 2, Purple 3 * Pigmentation: Normal 0, Hypopigmentation 1, Hyperpigmentation 2 * Pliability: Normal 0, Supple 1, Yielding 2, Firm 3, Ropes 4, Contracture 5 * Height: Flat (0), \< 2 mm (1), 2-5 mm (2), \> 5 mm (3) |
| Change in wound width | Baseline, 1 month, 3 months, 6 months | The mean wound width will be measured using a graduated Vernier caliper |
Countries
Egypt